Glycomimetics Inc (GLYC)

Last Year

29-Apr-23 -- 28-Apr-24

Time Period:

$90.26K Net Amount

Buy:	$90.26K	$1.38
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

18

0

5

+1

1

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-24 4:05 PM View:	29-Mar-24 Grant $13.75K	Goldberg Mark Alan Director		Glycomimetics Inc - GLYC	117% 16.75K to 36.33K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:05 PM View:	29-Mar-24 Grant $15.63K	Junius Daniel M Director		Glycomimetics Inc - GLYC	56% 63.25K to 98.46K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 4:10 PM View:	01-Jun-23 Option Exercise $12.60K	Koenig Scott Director		Glycomimetics Inc - GLYC	133% 15.75K to 36.75K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:05 PM View:	29-Dec-23 Grant $12.25K	Andrews Patricia S Director		Glycomimetics Inc - GLYC	30% 45.25K to 58.61K	0	0	--	--	Show Txns Hide Txns

18-May-23 4:27 PM View:	17-May-23 Private Sale ($7.22K)	Hahn Brian M. SVP Finance, CFO		Glycomimetics Inc - GLYC	(7%) 56.84K to 53.14K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:05 PM View:	29-Mar-24 Grant $10.00K	King Rachel K. Director		Glycomimetics Inc - GLYC	2% 646.6K to 659.1K	0	0	--	--	Show Txns Hide Txns

25-Sep-23 4:21 PM View:	22-Sep-23 Market Purchase $41.96K	Rock Edwin Chief Medical Officer		Glycomimetics Inc - GLYC	21% 310.0K to 375.4K	$90.26K 21%	0	$1.38	--	Show Txns Hide Txns

09-May-23 5:00 PM View:	08-May-23 Purchase $21.20K	Johnson Bruce S SVP & Chief Commercial Officer		Glycomimetics Inc - GLYC	11% 125.48K to 138.98K	0	0	--	--	Show Txns Hide Txns